Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 440

1.

Liver-specific 3D sectioning molds for correlating in vivo CT and MRI with tumor histopathology in woodchucks (Marmota monax).

Mikhail AS, Mauda-Havakuk M, Partanen A, Karanian JW, Pritchard WF, Wood BJ.

PLoS One. 2020 Mar 26;15(3):e0230794. doi: 10.1371/journal.pone.0230794. eCollection 2020.

2.

Impact of bowel preparation with Fleet's™ enema on prostate MRI quality.

Coskun M, Mehralivand S, Shih JH, Merino MJ, Wood BJ, Pinto PA, Barrett T, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2020 Mar 25. doi: 10.1007/s00261-020-02487-6. [Epub ahead of print]

PMID:
32211948
3.

Spatial density and diversity of architectural histology in prostate cancer: influence on diffusion weighted magnetic resonance imaging.

Harmon SA, Brown GT, Sanford T, Mehralivand S, Shih JH, Xu S, Merino MJ, Choyke PL, Pinto PA, Wood BJ, McKenney JK, Turkbey B.

Quant Imaging Med Surg. 2020 Feb;10(2):326-339. doi: 10.21037/qims.2020.01.06.

4.

Quality of Prostate MRI: Is the PI-RADS Standard Sufficient?

Sackett J, Shih JH, Reese SE, Brender JR, Harmon SA, Barrett T, Coskun M, Madariaga M, Marko J, Law YM, Turkbey EB, Mehralivand S, Sanford T, Lay N, Pinto PA, Wood BJ, Choyke PL, Turkbey B.

Acad Radiol. 2020 Mar 3. pii: S1076-6332(20)30080-5. doi: 10.1016/j.acra.2020.01.031. [Epub ahead of print]

PMID:
32143993
5.

MRI-Targeted, Systematic, and Combined Biopsy for Prostate Cancer Diagnosis.

Ahdoot M, Wilbur AR, Reese SE, Lebastchi AH, Mehralivand S, Gomella PT, Bloom J, Gurram S, Siddiqui M, Pinsky P, Parnes H, Linehan WM, Merino M, Choyke PL, Shih JH, Turkbey B, Wood BJ, Pinto PA.

N Engl J Med. 2020 Mar 5;382(10):917-928. doi: 10.1056/NEJMoa1910038.

PMID:
32130814
6.

Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.

Pritchard WF, Woods DL, Esparza-Trujillo JA, Starost MF, Mauda-Havakuk M, Mikhail AS, Bakhutashvili I, Leonard S, Jones EC, Krishnasamy V, Karanian JW, Wood BJ.

J Vasc Interv Radiol. 2020 Feb 24. pii: S1051-0443(19)30783-3. doi: 10.1016/j.jvir.2019.08.031. [Epub ahead of print]

PMID:
32107125
7.

Generalizing Deep Learning for Medical Image Segmentation to Unseen Domains via Deep Stacked Transformation.

Zhang L, Xu D, Xu Z, Wang X, Yang D, Sanford T, Harmon S, Turkbey B, Wood BJ, Roth H, Myronenko A.

IEEE Trans Med Imaging. 2020 Feb 12. doi: 10.1109/TMI.2020.2973595. [Epub ahead of print]

PMID:
32070947
8.

Augmented and Mixed Reality: Technologies for Enhancing the Future of IR.

Park BJ, Hunt SJ, Martin C 3rd, Nadolski GJ, Wood BJ, Gade TP.

J Vasc Interv Radiol. 2020 Feb 12. pii: S1051-0443(19)30825-5. doi: 10.1016/j.jvir.2019.09.020. [Epub ahead of print] Review.

PMID:
32061520
9.

Docosahexaenoic acid protects motor function and increases dopamine synthesis in a rat model of Parkinson's disease via mechanisms associated with increased protein kinase activity in the striatum.

Chitre NM, Wood BJ, Ray A, Moniri NH, Murnane KS.

Neuropharmacology. 2020 May 1;167:107976. doi: 10.1016/j.neuropharm.2020.107976. Epub 2020 Jan 27.

PMID:
32001239
10.

Immune checkpoint blockade in combination with stereotactic body radiotherapy in patients with metastatic pancreatic ductal adenocarcinoma.

Xie C, Duffy A, Brar G, Fioravanti S, Mabry-Hrones D, Walker M, Monge Bonilla C, Wood BJ, Citrin DE, Gil Ramirez EM, Escorcia FE, Redd B, Hernandez JM, Davis JL, Gasmi B, Kleiner D, Steinberg SM, Jones JC, Greten TF.

Clin Cancer Res. 2020 Jan 29. pii: clincanres.3624.2019. doi: 10.1158/1078-0432.CCR-19-3624. [Epub ahead of print]

PMID:
31996388
11.

Rapid perceptual processing in two- and three-dimensional prostate images.

Treviño M, Turkbey B, Wood BJ, Pinto PA, Czarniecki M, Choyke PL, Horowitz TS.

J Med Imaging (Bellingham). 2020 Mar;7(2):022406. doi: 10.1117/1.JMI.7.2.022406. Epub 2020 Jan 3.

PMID:
31930156
12.

Single-Step Methodology for Genomic Evaluation in Turkeys (Meleagris gallopavo).

Abdalla EEA, Schenkel FS, Emamgholi Begli H, Willems OW, van As P, Vanderhout R, Wood BJ, Baes CF.

Front Genet. 2019 Dec 20;10:1248. doi: 10.3389/fgene.2019.01248. eCollection 2019.

13.

Smartphone Augmented Reality CT-Based Platform for Needle Insertion Guidance: A Phantom Study.

Hecht R, Li M, de Ruiter QMB, Pritchard WF, Li X, Krishnasamy V, Saad W, Karanian JW, Wood BJ.

Cardiovasc Intervent Radiol. 2020 Jan 8. doi: 10.1007/s00270-019-02403-6. [Epub ahead of print]

PMID:
31915907
14.

The Feasibility of Using a Smartphone Magnetometer for Assisting Needle Placement.

Zhao Z, Xu S, Wood BJ, Ren H, Tse ZTH.

Ann Biomed Eng. 2020 Apr;48(4):1147-1156. doi: 10.1007/s10439-019-02436-5. Epub 2019 Dec 12.

15.

Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 Dec 5. doi: 10.1007/s11255-019-02354-4. [Epub ahead of print]

PMID:
31807974
16.

High-Intensity Focused Ultrasound (HIFU) Triggers Immune Sensitization of Refractory Murine Neuroblastoma to Checkpoint Inhibitor Therapy.

Eranki A, Srinivasan P, Ries M, Kim A, Lazarski CA, Rossi CT, Khokhlova TD, Wilson E, Knoblach SM, Sharma KV, Wood BJ, Moonen C, Sandler AD, Kim PCW.

Clin Cancer Res. 2020 Mar 1;26(5):1152-1161. doi: 10.1158/1078-0432.CCR-19-1604. Epub 2019 Oct 15.

PMID:
31615935
17.

Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.

Turkbey B, Czarniecki M, Shih JH, Harmon SA, Agarwal PK, Apolo AB, Citrin DE, Gulley JL, Harisinghani M, Madan RA, Metwalli AR, Paquette E, Pinto PA, Rais-Bahrami S, Rowe LS, Wood BJ, Jacobs PM, Lindenberg L, Dahut W, Choyke PL.

AJR Am J Roentgenol. 2020 Jan;214(1):105-113. doi: 10.2214/AJR.19.21264. Epub 2019 Oct 15.

PMID:
31613660
18.

Tumor Cell Biodiversity Drives Microenvironmental Reprogramming in Liver Cancer.

Ma L, Hernandez MO, Zhao Y, Mehta M, Tran B, Kelly M, Rae Z, Hernandez JM, Davis JL, Martin SP, Kleiner DE, Hewitt SM, Ylaya K, Wood BJ, Greten TF, Wang XW.

Cancer Cell. 2019 Oct 14;36(4):418-430.e6. doi: 10.1016/j.ccell.2019.08.007. Epub 2019 Oct 3.

19.

A multiparametric magnetic resonance imaging-based virtual reality surgical navigation tool for robotic-assisted radical prostatectomy.

Mehralivand S, Kolagunda A, Hammerich K, Sabarwal V, Harmon S, Sanford T, Gold S, Hale G, Romero VV, Bloom J, Merino MJ, Wood BJ, Kambhamettu C, Choyke PL, Pinto PA, Türkbey B.

Turk J Urol. 2019 Sep 1;45(5):357-365. doi: 10.5152/tud.2019.19133. Print 2019 Sep.

20.

Apical periurethral transition zone lesions: MRI and histology findings.

Tuncer S, Mehralivand S, Harmon SA, Sanford T, Brown GT, Rowe LS, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2019 Aug 29. doi: 10.1007/s00261-019-02194-x. [Epub ahead of print]

PMID:
31468153
21.

Real-time fluorescence imaging for visualization and drug uptake prediction during drug delivery by thermosensitive liposomes.

Motamarry A, Negussie AH, Rossmann C, Small J, Wolfe AM, Wood BJ, Haemmerich D.

Int J Hyperthermia. 2019;36(1):817-826. doi: 10.1080/02656736.2019.1642521.

22.

Radiofrequency Ablation Duration per Tumor Volume May Correlate with Overall Survival in Solitary Hepatocellular Carcinoma Patients Treated with Radiofrequency Ablation Plus Lyso-Thermosensitive Liposomal Doxorubicin.

Celik H, Wakim P, Pritchard WF, Castro M, Leonard S, Karanian JW, Dewhirst MW, Lencioni R, Wood BJ.

J Vasc Interv Radiol. 2019 Dec;30(12):1908-1914. doi: 10.1016/j.jvir.2019.04.023. Epub 2019 Aug 10.

PMID:
31409568
23.

Genetic parameters for clutch and broodiness traits in turkeys (Meleagris Gallopavo) and their relationship with body weight and egg production.

Emamgholi Begli H, Wood BJ, Abdalla EA, Balzani A, Willems O, Schenkel F, Harlander-Matauschek A, Baes CF.

Poult Sci. 2019 Dec 1;98(12):6263-6269. doi: 10.3382/ps/pez446.

24.

Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance.

Bloom JB, Lebastchi AH, Gold SA, Hale GR, Sanford T, Mehralivand S, Ahdoot M, Rayn KN, Czarniecki M, Smith C, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

BJU Int. 2019 Nov;124(5):768-774. doi: 10.1111/bju.14835. Epub 2019 Jun 26.

PMID:
31141307
25.

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 Aug;51(8):1349-1355. doi: 10.1007/s11255-019-02168-4. Epub 2019 May 16.

PMID:
31098818
26.

Tissue-mimicking thermochromic phantom for characterization of HIFU devices and applications.

Eranki A, Mikhail AS, Negussie AH, Katti PS, Wood BJ, Partanen A.

Int J Hyperthermia. 2019;36(1):518-529. doi: 10.1080/02656736.2019.1605458.

27.

Assessment of the response of hepatocellular carcinoma to interventional radiology treatments.

Patella F, Pesapane F, Fumarola E, Zannoni S, Brambillasca P, Emili I, Costa G, Anderson V, Levy EB, Carrafiello G, Wood BJ.

Future Oncol. 2019 May;15(15):1791-1804. doi: 10.2217/fon-2018-0747. Epub 2019 May 2.

PMID:
31044615
28.

Eye Tracking for Deep Learning Segmentation Using Convolutional Neural Networks.

Stember JN, Celik H, Krupinski E, Chang PD, Mutasa S, Wood BJ, Lignelli A, Moonis G, Schwartz LH, Jambawalikar S, Bagci U.

J Digit Imaging. 2019 Aug;32(4):597-604. doi: 10.1007/s10278-019-00220-4.

29.

Immunotherapy and the Interventional Oncologist: Challenges and Opportunities-A Society of Interventional Oncology White Paper.

Erinjeri JP, Fine GC, Adema GJ, Ahmed M, Chapiro J, den Brok M, Duran R, Hunt SJ, Johnson DT, Ricke J, Sze DY, Toskich BB, Wood BJ, Woodrum D, Goldberg SN.

Radiology. 2019 Jul;292(1):25-34. doi: 10.1148/radiol.2019182326. Epub 2019 Apr 23. Review.

PMID:
31012818
30.

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

Greer MD, Shih JH, Lay N, Barrett T, Bittencourt L, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536. [Epub ahead of print]

PMID:
30917023
31.

Combined locoregional-immunotherapy for liver cancer.

Greten TF, Mauda-Havakuk M, Heinrich B, Korangy F, Wood BJ.

J Hepatol. 2019 May;70(5):999-1007. doi: 10.1016/j.jhep.2019.01.027. Epub 2019 Feb 7. Review.

PMID:
30738077
32.

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2019 Mar;290(3):709-719. doi: 10.1148/radiol.2018181278. Epub 2019 Jan 22.

33.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30577395
34.

Intra- and interreader reproducibility of PI-RADSv2: A multireader study.

Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, An JY, Czarniecki M, Mehralivand S, Coskun M, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2019 Jun;49(6):1694-1703. doi: 10.1002/jmri.26555. Epub 2018 Dec 21.

PMID:
30575184
35.

Analyzing the current practice patterns and views among urologists regarding focal therapy for prostate cancer.

Jain AL, Sidana A, Maruf M, Sugano D, Calio B, Wood BJ, Pinto PA.

Urol Oncol. 2019 Mar;37(3):182.e1-182.e8. doi: 10.1016/j.urolonc.2018.11.018. Epub 2018 Dec 3.

PMID:
30522903
36.

Learning deep similarity metric for 3D MR-TRUS image registration.

Haskins G, Kruecker J, Kruger U, Xu S, Pinto PA, Wood BJ, Yan P.

Int J Comput Assist Radiol Surg. 2019 Mar;14(3):417-425. doi: 10.1007/s11548-018-1875-7. Epub 2018 Oct 31.

PMID:
30382457
37.

Ultra-small superparamagnetic iron oxide contrast agents for lymph node staging of high-risk prostate cancer.

Czarniecki M, Pesapane F, Wood BJ, Choyke PL, Turkbey B.

Transl Androl Urol. 2018 Sep;7(Suppl 4):S453-S461. doi: 10.21037/tau.2018.05.15. Review.

38.

Can computer-aided diagnosis assist in the identification of prostate cancer on prostate MRI? a multi-center, multi-reader investigation.

Gaur S, Lay N, Harmon SA, Doddakashi S, Mehralivand S, Argun B, Barrett T, Bednarova S, Girometti R, Karaarslan E, Kural AR, Oto A, Purysko AS, Antic T, Magi-Galluzzi C, Saglican Y, Sioletic S, Warren AY, Bittencourt L, Fütterer JJ, Gupta RT, Kabakus I, Law YM, Margolis DJ, Shebel H, Westphalen AC, Wood BJ, Pinto PA, Shih JH, Choyke PL, Summers RM, Turkbey B.

Oncotarget. 2018 Sep 18;9(73):33804-33817. doi: 10.18632/oncotarget.26100. eCollection 2018 Sep 18.

39.

What Can Be Done to Improve Research Biopsy Quality in Oncology Clinical Trials?

Ferry-Galow KV, Datta V, Makhlouf HR, Wright J, Wood BJ, Levy E, Pisano ED, Tam AL, Lee SI, Mahmood U, Rubinstein LV, Doroshow JH, Chen AP.

J Oncol Pract. 2018 Oct 4:JOP1800092. doi: 10.1200/JOP.18.00092. [Epub ahead of print]

40.

Incidental bladder cancers found on multiparametric MRI of the prostate gland: a single center experience.

Rayn KN, Hale GR, Bloom JB, Gold SA, Carvalho FLF, Mehralivand S, Czarniecki M, Wood BJ, Merino MJ, Choyke P, Türkbey B, Pinto PA, Agarwal PK.

Diagn Interv Radiol. 2018 Sep;24(5):316-320. doi: 10.5152/dir.2018.18102. Review.

41.

Enhanced Drug Delivery to the Skin Using Liposomes.

Blueschke G, Boico A, Negussie AH, Yarmolenko P, Wood BJ, Spasojevic I, Fan P, Erdmann D, Schroeder T, Sauerbier M, Klitzman B.

Plast Reconstr Surg Glob Open. 2018 Jul 9;6(7):e1739. doi: 10.1097/GOX.0000000000001739. eCollection 2018 Jul.

42.

Mapping Drug Dose Distribution on CT Images Following Transarterial Chemoembolization with Radiopaque Drug-Eluting Beads in a Rabbit Tumor Model.

Mikhail AS, Pritchard WF, Negussie AH, Krishnasamy VP, Amchin DB, Thompson JG, Wakim PG, Woods D, Bakhutashvili I, Esparza-Trujillo JA, Karanian JW, Willis SL, Lewis AL, Levy EB, Wood BJ.

Radiology. 2018 Nov;289(2):396-404. doi: 10.1148/radiol.2018172571. Epub 2018 Aug 14.

43.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30063928
44.

Bench-to-clinic development of imageable drug-eluting embolization beads: finding the balance.

Lewis AL, Willis SL, Dreher MR, Tang Y, Ashrafi K, Wood BJ, Levy EB, Sharma KV, Negussie AH, Mikhail AS.

Future Oncol. 2018 Nov;14(26):2741-2760. doi: 10.2217/fon-2018-0196. Epub 2018 Jun 26. Review.

45.

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.

Rayn KN, Bloom JB, Gold SA, Hale GR, Baiocco JA, Mehralivand S, Czarniecki M, Sabarwal VK, Valera V, Wood BJ, Merino MJ, Choyke P, Turkbey B, Pinto PA.

J Urol. 2018 Nov;200(5):1041-1047. doi: 10.1016/j.juro.2018.05.094. Epub 2018 May 29.

PMID:
29852182
46.

Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.

Thai JN, Narayanan HA, George AK, Siddiqui MM, Shah P, Mertan FV, Merino MJ, Pinto PA, Choyke PL, Wood BJ, Turkbey B.

Radiology. 2018 Aug;288(2):485-491. doi: 10.1148/radiol.2018170425. Epub 2018 May 22.

47.

Follow-up of negative MRI-targeted prostate biopsies: when are we missing cancer?

Gold SA, Hale GR, Bloom JB, Smith CP, Rayn KN, Valera V, Wood BJ, Choyke PL, Turkbey B, Pinto PA.

World J Urol. 2019 Feb;37(2):235-241. doi: 10.1007/s00345-018-2337-0. Epub 2018 May 21. Review.

PMID:
29785491
48.

"Super-active surveillance": MRI ultrasound fusion biopsy and ablation for less invasive management of prostate cancer.

Bloom JB, Gold SA, Hale GR, Rayn KN, Sabarwal VK, Bakhutashvili I, Valera V, Turkbey B, Pinto PA, Wood BJ.

Gland Surg. 2018 Apr;7(2):166-187. doi: 10.21037/gs.2018.03.06. Review.

49.

Fusion prostate biopsy outperforms 12-core systematic prostate biopsy in patients with prior negative systematic biopsy: A multi-institutional analysis.

Sidana A, Watson MJ, George AK, Rastinehad AR, Vourganti S, Rais-Bahrami S, Muthigi A, Maruf M, Gordetsky JB, Nix JW, Merino MJ, Turkbey B, Choyke PL, Wood BJ, Pinto PA.

Urol Oncol. 2018 Jul;36(7):341.e1-341.e7. doi: 10.1016/j.urolonc.2018.04.002. Epub 2018 May 10.

PMID:
29753548
50.

Evaluating the size criterion for PI-RADSv2 category 5 upgrade: is 15 mm the best threshold?

An JY, Harmon SA, Mehralivand S, Czarniecki M, Smith CP, Peretti JA, Wood BJ, Pinto PA, Choyke PL, Shih JH, Turkbey B.

Abdom Radiol (NY). 2018 Dec;43(12):3436-3444. doi: 10.1007/s00261-018-1631-z.

PMID:
29752491

Supplemental Content

Support Center